Thermo Fisher Partners with Wuxi Diagnostics and Mayo Clinic for Developing New COVID-19 Serology Test
Thermo Fisher Scientific Inc. (Waltham, MA, USA) will be developing a total antibodies test in collaboration with Wuxi Diagnostics (Shanghai, China) and Mayo Clinic (Rochester, NY, USA). More...15 May 2020
Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit
Applied DNA Sciences Inc. (Stony Brook, NY, USA) has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for the clinical use of the company’s patent-pending Linea COVID-19 RT-PCR test. More...15 May 2020
EKF and Tosoh Europe N.V. Sign Distribution Agreement for Quo-Test HbA1c POC Analyzer in Middle East and Africa
EKF Diagnostics has signed a three-year distribution agreement with (Cardiff, UK) Tosoh Europe N.V. (Tessenderlo, Belgium) for the distribution of its Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa. More...15 May 2020
Sweden’s Coronavirus Strategy Targeting Herd Immunity Could be Adopted Globally, Say Analysts
Augmenting herd immunity against COVID-19 is part of the Swedish government’s broader strategy—or at least a likely consequence of keeping schools, restaurants, and most businesses open— that is likely to be imitated by other countries across the world. More...14 May 2020
In Other News
Moderna’s mRNA Vaccine (mRNA-1273) Against Novel Coronavirus Awarded Fast-Track Designation by FDA
Thermo Fisher SARS‑CoV‑2 Multiplex Real-Time PCR Test Granted Expanded EUA by FDA
New One Minute Coronavirus Test Offers More than 90% Accuracy at Dramatically Lower Price
FDA Issues New Guidance to Accelerate Development of Prevention and Treatment Options for COVID-19
New Artificial Intelligence Algorithm Accurately Predicts COVID-19 Without Testing
Clinical Trial to Evaluate Drug Combination of Gilead’s Remdesivir and Eli Lilly’s Baricitinib for COVID-19 Treatment
Airtouch Portable X-Ray System Receives FDA Clearance for Human Medical Use
Ortho COVID-19 Total Antibody Test Receives CE Mark
Abbott Granted FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity m System
Researchers Use AI System to Map Novel Cardiac Features Of COVID-19
Triple Drug Cocktail Antiviral Therapy Alleviates COVID-19 Symptoms and Shortens Hospital Stay, Finds New Study
Abbott COVID-19 Antibody Blood Test on Alinity i System Granted FDA Emergency Use Authorization
China’s COVID-19 Vaccine Induces SARS-CoV-2-Specific Neutralizing Antibodies in First Animal Study
Abbott's SARS-CoV-2 Antibody Blood Test Demonstrates High Performance in Validation Study
New Purpose-Built COVID-19 LIMS Solution Jump-Starts COVID-19 Testing and Research
FDA Permits Use of Aidoc's AI Algorithms to Detect and Prioritize Incidental CT Findings Associated with COVID-19
Quidel’s Sofia 2 SARS Antigen FIA Becomes First COVID-19 Antigen Test to Secure FDA Emergency Use Authorization
Pluristem’s IND Application for Phase II Study of PLX Cells for COVID-19 Treatment Receives FDA Clearance
EMA Fast-Tracks Development, Support and Approval of COVID-19 Medicines and Vaccines
Johns Hopkins Launches New COVID-19 Testing Insights Initiative
Study of Potential COVID-19 Drug Initially Under Development for Psoriasis Progresses to Phase II
Tonix Pharmaceuticals to Develop Three New Horsepox-Based COVID-19 Vaccines
Sorrento and Mount Sinai to Jointly Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection